Clinical trial
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
Recruiting now · Not applicable · 1 countries · Registry ID NCT05147909
What this study is about
Studies in mice demonstrated that dietary phosphate (Pi) loading that mimic the level of US adult consumption leads to reduced spontaneous locomotor activity, exercise capacity, and reduced resting metabolic rate when in normal mice by impairing skeletal muscle mitochondrial function and fat oxidation. However, relevance of this findings in humans remains unknown.
Basic eligibility
Full registry criteria
Treatments and study arms
Sodium Phosphate
Sodium Phosphate 2 capsules daily (containing a total of 500 mg of Pi, 372mg of sodium)
Sodium Chloride
Sodium Chloride 2 capsules daily (NaCl, containing a total of 372mg of sodium)
Primary outcomes
VO2 (ml of oxygen consumed /min) will be measured using a metabolic cart (Medgraphics) during exercise in a stationary bicycle. Standard breath-by-breath respiratory gases (VO2) will be measured at rest and after 3 minutes of steady state exercise at both 20 and 40 Watts using a cycle ergometer (Lode). Then, the partcipants will be asked to perform exercise to maximal level to obtain peak VO2.
Study locations
1 locations were listed when this page was built. The first 40 are shown.